Anemia Management Trends in Hospital-Based Dialysis Centers (HBDCs), 2010 to 2013-Reference-Cited by-同舟云学术

Anemia Management Trends in Hospital-Based Dialysis Centers (HBDCs), 2010 to 2013

Published:2014-03 Issue:3 Volume:36 Page:408-418
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Coritsidis George N.,Maglinte Gregory A.,Acharya Anjali,Saxena Anjali,Chang Chun-Lan,Hill Jerrold,Gitlin Matthew,Lafayette Richard A.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference36 articles.

1. Aranesp (darbepoetin alfa) [prescribing information]. Thousand Oaks, Calif: Amgen Inc; 2012.

2. Epogen (epoetin alfa) [prescribing information]. Thousand Oaks, Calif: Amgen Inc; 2012.

3. National Kidney Foundation. The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-KDOQI). http://www.kidney.org/professionals/kdoqi/. Accessed May 24, 2013.

4. KDIGO clinical practice guideline for anemia in chronic kidney disease;Kidney Int Suppl,2012

5. Department of Health and Human Services: Centers for Medicare & Medicaid Services. End Stage Renal Disease Prospective Payment System: Final Rule and Proposed Rule, CMS-1418-F, RIN 0938-AP57, 42 CFR Parts 410, 413 and 414. August 12, 2010.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective;Journal of Managed Care & Specialty Pharmacy;2021-12

2. Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review;Journal of Medical Economics;2019-03-27

3. Variability in hemoglobin levels in hemodialysis patients in the current era: a retrospective cohort study;Clinical Nephrology;2017-11-01

4. Costs Associated With Intravenous Darbepoetin Versus Epoetin Therapy in Hemodialysis Patients: A Randomized Controlled Trial;Canadian Journal of Kidney Health and Disease;2017-01

5. The Impact of Lowering Haemoglobin Targets on Patterns of Erythropoiesis-Stimulating Agent Use in Patients on Haemodialysis;Blood Purification;2016